Continuous venous-venous hemofiltration therapy on the markers for endothelial injury in systemic inflammatory response syndrome and sepsis patients

Jun XUE,Junfeng LIU,Mingxin LI,Xuefeng SHI,Feng DING,Fuming LU,Yong GU,Shanyan LIN
DOI: https://doi.org/10.3969/j.issn.1671-4091.2007.10.007
2007-01-01
Abstract:Objective Efforts were made to investigate the effects of continuous venous-venous hemofiltration (CVVH) on the markers for endothelial injury in systemic inflammatory response syndrome and sepsis (SIRS/sepsis) patients. Methods Soluble thrombomodulin (sTM),soluble intercellular adhesion mol-ecule-1 (sICAM-1),soluble E-selectin in plasma were measured by ELISA before and after CVVH treatment in 15 SIRS/sepsis patients. APACH Ⅱ scores were used to evaluate the CVVH effects. Results APACH Ⅱ scores improved on the 4th day after the treatment in 8 SIRS patients,but worsened in 7 sepsis patients. Plasma sTM,sICAM-1 and E-selectin were significantly higher in SIRS/sepsis patients than in normal controls,and were higher in sepsis patients than in SIRS patients. On the 7th after the treatment,plasma sTM and sE-selectin de-creased remarkably in SIRS patients but not in sepsis patients. Conclusion Endothelial activation and injury occur in SIRS/sepsis patients. CVVH can partially improve the endothelial function in SIRS patients but not in sepsis patients.
What problem does this paper attempt to address?